Cooper, T. M., Absalon, M. J., Alonzo, T. A., Gerbing, R. B., Leger, K. J., Hirsch, B. A., . . . Kolb, E. A. (2020). Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children’s Oncology Group. J Clin Oncol.
Citação norma ChicagoCooper, Todd M., et al. "Phase I/II Study of CPX-351 Followed By Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children’s Oncology Group." J Clin Oncol 2020.
MLA CitationCooper, Todd M., et al. "Phase I/II Study of CPX-351 Followed By Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children’s Oncology Group." J Clin Oncol 2020.